---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-007798"
form_type: "8-K"
ticker: "PBSV"
cik: "0001304161"
company_name: "Pharma-Bio Serv, Inc."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:15:44.554513+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pharma-Bio Serv Q2 revenue down 48% to $2.4M; net loss $0.2M vs income $0.4M

## Summary
- Q2 revenue $2.4M, decline of $2.2M from $4.6M in prior-year quarter.
- Net loss $0.2M for the quarter; prior-year period net income was $0.4M.
- Six-month revenue $4.8M, down $4.0M; net loss of $0.5M vs income $0.8M.
- Management attributing decline to planned FY2024 investments in new client relationships and global events.

## SEC filing metadata
- accession: 0001654954-24-007798
- form_type: 8-K
- ticker: PBSV
- cik: 0001304161
- company_name: Pharma-Bio Serv, Inc.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1304161/000165495424007798/0001654954-24-007798-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1304161/000165495424007798/pbsv_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-007798
- JSON: https://secwatch.observer/filing/0001654954-24-007798.json
- Plain text: https://secwatch.observer/filing/0001654954-24-007798.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.